NUTRISENS
DEAD

Serial Number

79211317

Owner

NUTRISENS

Attorney

Timothy R. DeWitt

Filing Date

Apr 5, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NUTRISENS Trademark

Serial Number: 79211317

NUTRISENS is a trademark filed by NUTRISENS on April 5, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NUTRISENS

3 CHEMIN DES CYTISES

Entity Type: 34

Trademark Details

Filing Date

April 5, 2017

Registration Date

Not Registered

Goods & Services

dietetic foods adapted for medical use, namely, chopped and mixed cooked dishes and ready-to-mix food preparations, for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases; pharmaceutical preparations for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases; dietetic beverages adapted for medical use, for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, namely, fruit beverages, dairy drinks, vegetable drinks; pharmaceutical preparations and substances for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases; dietetic foods adapted for medical use, for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, namely, nutritionally fortified food products; food supplements; amino acids for medical purposes, for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases; vitamins; dietetic foods adapted for medical use, for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, namely, dairy-based cream desserts, vegetable-based cream desserts, fruit purees, vegetable purees, soups, breakfast cereals, bread, biscuits, chocolate, cakes, high protein soluble powders to rehydrate; dietetic substances for medical use, for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, namely, dairy-based cream desserts, vegetable-based cream desserts, fruit purees, vegetable purees, soups, breakfast cereals, bread, biscuits, chocolate, cakes, high protein soluble powders to rehydrate; food supplements based on meat, fruit and milk for medical use; nutritional and dietetic supplements; medicinal infusions for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases; pharmaceutical products for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases; nutritional supplement mixtures for beverages in the form of powders; dietetic sugar for medical use, for preventing and treating protein-energy malnutrition and dehydration due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases, for preventing dysphagia due to diseases, illnesses or age-related illnesses, such as Alzheimer's diseases

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 30, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 23, 2019 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Aug 8, 2019 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 8, 2019 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2019 TCCA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 28, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 12, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 12, 2018 OPNR
ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Aug 8, 2018 MAB0
ABANDONMENT - INCOMPLETE RESPONSE
Aug 8, 2018 ABN0
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 6, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 6, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 5, 2018 GNFN
FINAL REFUSAL E-MAILED
Feb 5, 2018 GNFR
FINAL REFUSAL WRITTEN
Feb 5, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 15, 2018 TROA
REFUSAL PROCESSED BY IB
Aug 4, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 20, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 20, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 15, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 14, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 11, 2017 MAFR
ASSIGNED TO EXAMINER
Jul 7, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 6, 2017 REPR